Sofía González-Ortiz

Dr. Sofía González-Ortiz

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
AMAlejandra Mosteiro
Alejandra Mosteiro
ASAlberto Di Somma
Alberto Di Somma
PRPedro Roldan Ramos
Pedro Roldan Ramos
AFAbel Ferrés
Abel Ferrés
ARAndrea De Rosa
Andrea De Rosa
JGJose Juan González
Jose Juan González
Objective: Intraoperative imaging is a chief asset in neurosurgical oncology, it improves the extent of resection and postoperative outcomes. Imaging devices have evolved considerably, in particular ultrasound (iUS) and magnetic resonance (iMR). Although iUS is regarded as a more economically convenient and yet effective asset, no formal comparison between the efficiency of iUS and iMR in neurosurgical oncology has been performed.Methods: A cost-effectiveness analysis comparing two single-center prospectively collected surgical cohorts, classified according to the intraoperative imaging used. iMR (2013-2016) and iUS (2021-2022) groups comprised low- and high-grade gliomas, with a maximal safe resection intention. Units of health gain were gross total resection and equal or increased Karnofsky performance status. Surgical and health costs were considered for analysis. The incremental cost-effectiveness ratio (ICER) was calculated for the two intervention alternatives. The cost-utility graphic and the evolution of surgical duration with the gained experience were also analyzed.Results: 50 patients followed an iMR-assisted operation, while 17 underwent an iUS-guided surgery. Gross total resection was achieved in 70% with iMR and in 60% with iUS. Median postoperative Karnofsky was similar in both group (KPS 90). Health costs were € 3,220 higher with iMR, and so were surgical-related costs (€ 1,976 higher). The ICER was € 322 per complete resection obtained with iMR, and € 644 per KPS gained or maintained with iMR. When only surgical-related costs were analyzed, ICER was € 198 per complete resection with iMR and € 395 per KPS gained or maintained.Conclusion: This is an unprecedented but preliminary cost-effectiveness analysis of the two most common intraoperative imaging devices in neurosurgical oncology. iMR, although being costlier and time-consuming, seems cost-effective in terms of complete resection rates and postoperative performance status. However, the differences between both techniques are small. Possibly, iMR and iUS are complementary aids during the resection: iUS real-time images assist while advancing towards the tumor limits, informing about the distance to relevant landmarks and correcting neuronavigation inaccuracy due to brain shift. Yet, at the end of resection, it is the iMR that reliably corroborates whether residual tumor remains.

5 April 2021 in Journal of Neuroimaging
Verified
Journal Article
Closed access
PDF file
SGSofía González-Ortiz
Sofía González-Ortiz
SMSantiago Medrano
Santiago Medrano
JCJaume Capellades
Jaume Capellades
MVMarta Vilas
Marta Vilas
AMAntoni Mestre
Antoni Mestre
RRRodrigo Rocamora
Rodrigo Rocamora

19 November 2025 in Insights into Imaging
Verified
Journal Article
Open access
GAGary Amseian
Gary Amseian
FAFrancisco Aya
Francisco Aya
CPCamilo Pineda
Camilo Pineda
SGSofía González-Ortiz
Sofía González-Ortiz
JMJuan-Andrés Mora
Juan-Andrés Mora
LOLaura Oleaga
Laura Oleaga
Immunotherapy, particularly immune checkpoint inhibitors, plays a crucial role in the treatment of brain metastases in various primary cancers. Response assessment encompasses atypical patterns, including pseudoprogression, hyperprogression, or dissociated response, which present greater complexity than classical patterns defined by standardized response assessment criteria. Additionally, intracranial adverse events like hypophysitis or encephalitis may resemble tumor progression. Accurate evaluation and management of brain metastases during immunotherapy requires that radiologists are familiar with both classical and atypical response patterns, as well as potential intracranial adverse events. Brain MRI and advanced imaging techniques serve as essential tools for this purpose. Critical relevance statement: Assessing brain metastases response to immunotherapy accurately is fundamental for therapeutic decision-making. Radiologists must recognize classical and atypical responses and adverse events associated with immunotherapy to ensure optimal patient management. Key Points: Immunotherapy response assessment in brain metastases is complex due to atypical patterns including pseudoprogression, hyperprogression, and dissociated responses. Immunotherapy-induced intracranial adverse events, such as hypophysitis and encephalitis, must be accurately identified. Brain MRI, complemented by advanced imaging techniques (perfusion MRI, MRS, and amino acid PET), is crucial for distinguishing these complex scenarios. Graphical

5 March 2025 in Neuroradiology
Verified
Journal Article
Open access
PDF file
FLFrancesca De Luca
Francesca De Luca
JZJose Pariente Zorrilla
Jose Pariente Zorrilla
SGSofía González-Ortiz
Sofía González-Ortiz
ECEstefanía Conde-Blanco
Estefanía Conde-Blanco
MCMar Carreño
Mar Carreño
NBNuria Bargallo
Nuria Bargallo
Purpose: This study compared two image post-processing toolboxes primarily designed for focal cortical dysplasia (FCD): Multi-Centre Epilepsy Lesion Detection (MELD) and Morphometric Analysis Program (MAP18), in identifying temporal lobe epilepsy (TLE) structural lesions on MRI. Methods: This retrospective study examined 79 adults, 58 patients with confirmed TLE, and 21 healthy controls. All participants underwent an elective brain MRI between June 2007 – May 2023 at Hospital Clinic, Barcelona, Spain. All the 3D T1-weighted images were processed using MELD and MAP18 to detect potential epileptogenic lesions. The location (lateral or mesial) and laterality of the reference TLE structural lesion (refTLE) were determined through histopathology or multidisciplinary consensus based on clinical data. Toolboxes’ performance was evaluated using descriptive statistics, specificity, and diagnostic accuracy. Additionally, a second-look MRI was conducted for cases where abnormalities detected by MELD and MAP18 did not match the refTLE. Results: MELD and MAP18 demonstrated variability in specificity and diagnostic accuracy. Specificity ranged from 48% to 86%, with ProbMAP (MAP18) achieving the highest values. Global diagnostic accuracy ranged from 7% to 42%, with MELD showing the highest performance. In four patients with visible epileptogenic lesions on MRI, MELD and MAP18 identified additional abnormalities that were previously overlooked. Moreover, MELD detected one TLE lesion in one patient initially classified as MRI–negative (nonlesional). Conclusion: Incorporating tools like MELD and MAP18 into the diagnostic workflow can enhance the detection of TLE-related abnormalities on MRI, potentially improving patient outcomes and aiding in clinical decision-making.

30 November 2020 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
SGSofía González-Ortiz
Sofía González-Ortiz
SMSantiago Medrano
Santiago Medrano
JMJosé María Maiques
José María Maiques
JCJaume Capellades
Jaume Capellades
Challenges in Neuroimaging in COVID-19 Pandemia

12 December 2024 in Epilepsia Open
Verified
Journal Article
Open access
AJAleix Jareno‐Badenas
Aleix Jareno‐Badenas
MMMario Matute‐González
Mario Matute‐González
Luis PintorLuis Pintor
Luis Pintor
ECEstefanía Conde‐Blanco
Estefanía Conde‐Blanco
MCMar Carreño
Mar Carreño
SGSofía González-Ortiz
Sofía González-Ortiz
Objective: Psychogenic non‐epileptic seizures (PNES) mimic epileptic seizures without electroencephalographic correlation. Although classified as psychiatric disorders, their neurobiological or structural basis remains unclear. This study aimed to assess the prevalence and characteristics of MRI abnormalities in patients with PNES and those with comorbid epilepsy, compared to the general population, to enhance radiological evaluation and management.Method: We retrospectively identified patients with a definitive diagnosis of PNES, evaluated in the refractory epilepsy unit of our tertiary epilepsy center. Patients were classified into two groups according to their comorbidity with epilepsy (PNES and PNES+). The MRI findings were evaluated and classified by two radiologists, who reported the category of the findings, laterality, and location. The two groups were compared using the chi‐square test, as well as the frequencies of findings in the general population extracted from the literature.Results: Forty‐six patients fulfilled the inclusion criteria. Thirty females and 16 males. MRI findings were present in 25/35 (71.4%) patients in the PNES group and 9/11 (81.8%) In the PNES + group, showing statistically significant differences in the frequency of findings with the general population (8.4–28.1%).Significance: MRI anomalies are common in PNES patients and even more prevalent in complex cases referred to epilepsy units, underscoring the necessity of correlating MRI findings with clinical‐electrical patterns.Plain Language Summary: In this article, we observed a higher frequency of cerebral magnetic resonance findings in patients with psychogenic non‐epileptic seizures than in the general population. We also observed a higher frequency of this pathology among women, as well as right cerebral hemisphere affections. The exposed findings suggest a potential structural basis of this pathology. This hypothesis requires confirmation with larger studies.